SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

CNTY-813, an iPSC-derived islet replacement therapy for T1D, presented new nonclinical data at the 6

IPSC

Related stories